GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » Net Income (Continuing Operations)

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Net Income (Continuing Operations) : ¥46 Mil (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Tonghua Golden-horse Pharmaceutical Industry Co's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was ¥9 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥46 Mil.


Tonghua Golden-horse Pharmaceutical Industry Co Net Income (Continuing Operations) Historical Data

The historical data trend for Tonghua Golden-horse Pharmaceutical Industry Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Golden-horse Pharmaceutical Industry Co Net Income (Continuing Operations) Chart

Tonghua Golden-horse Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,042.94 -360.66 33.99 29.19 43.23

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.72 3.58 4.55 28.37 9.17

Tonghua Golden-horse Pharmaceutical Industry Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tonghua Golden-horse Pharmaceutical Industry Co  (SZSE:000766) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Tonghua Golden-horse Pharmaceutical Industry Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Executives
Wei Ying Jie Director
Zan Bao Shi Director
Wu Cheng Yu Directors, executives
Zhang De Ju Supervisors
Li Ju Supervisors
Feng Ran Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines